Aurora Cannabis Inc. (NASDAQ:ACB) ranks among the best sin stocks to buy in 2026. Aurora Cannabis Inc. (NASDAQ:ACB) has recently been making significant market growth in Europe and Australia, with the company stating on December 2 that its subsidiary, MedReleaf Australia, has signed a distribution agreement with Leafio, Montu Australia’s wholesale arm. The partnership intends to give medical professionals training materials while expanding patient access to medical cannabis products throughout Australia. ...

Core Insights - Aurora Cannabis Inc. is launching its Whistler Cannabis Co. brand in Australia, expanding its global footprint and offering Australian patients access to premium Canadian cannabis products [1][2][3] - The company emphasizes its commitment to quality and patient care, leveraging its Canadian cultivation expertise to ensure consistent product quality [2][3] Product Launch Details - The first two products from Whistler Cannabis Co. to be introduced in Australia are Ginger Breath and Critical Diesel, both featuring high THC content [7] - Ginger Breath has a THC level of 32% and is an Indica strain, while Critical Diesel has a THC level of 28% and is a Sativa strain [7] Company Background - Aurora Cannabis Inc. is a leading global medical cannabis company headquartered in Edmonton, Alberta, with a diverse portfolio of brands serving both medical and consumer markets across multiple regions [4][5] - The company is recognized for its robust regulatory expertise and commitment to science and innovation, which supports its success in international markets [3][4]